REGENXBIO Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 6.4M | 30.3M | 29.7M | 21.4M | 89.0M | 21.2M | 24.2M | 22.3M |
| Cost of Goods Sold | 11.1M | 5.9M | 61.8M | 9.1M | 3.4M | 6.3M | 12.4M | 14.6M |
| Gross Profit | -4.7M | 24.4M | -32.1M | 12.2M | 85.6M | 14.9M | 11.8M | 7.7M |
| R&D Expenses | 57.3M | 59.6M | 56.1M | 55.6M | 53.1M | 50.4M | 54.4M | 44.8M |
| Operating Expenses | 78.7M | 82.0M | 20.3M | 75.5M | 73.4M | 66.3M | 73.9M | 63.7M |
| Operating Income | -83.4M | -57.6M | -52.4M | -63.3M | 12.1M | -51.4M | -62.1M | -56.0M |
| Other Income / Gains | -6.7M | -9.5M | -9.5M | -7.6M | -6.0M | 182K | 2.5M | 3.0M |
| Net Income | -90.1M | -67.1M | -61.9M | -70.9M | 6.1M | -51.2M | -59.6M | -53.0M |
| EPS (Diluted) | -1.72 | -1.30 | -1.20 | -1.38 | 0.12 | -1.01 | -1.17 | -1.05 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | -0.732 | 0.805 | -1.079 | 0.573 | 0.961 | 0.702 | 0.488 | 0.344 |
| General And Administrative Expenses | 21.3M | 22.4M | 20.3M | 19.9M | 20.3M | 20.1M | 19.4M | 18.9M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 21.3M | 22.4M | 20.3M | 19.9M | 20.3M | 20.1M | 19.4M | 18.9M |
| Other Expenses | 36K | 54K | -56.0M | 45K | 15K | -4.2M | 37K | 29K |
| Cost And Expenses | 89.8M | 88.0M | 82.1M | 84.6M | 76.9M | 72.6M | 86.3M | 78.3M |
| Interest Income | 16K | 18K | 19K | 3.4M | 25K | 83K | 25K | 29K |
| Interest Expense | 8.7M | 12.3M | 13.2M | 11.0M | 8.6M | 9.4M | 820K | 449K |
| Depreciation And Amortization | 3.9M | 3.9M | 3.9M | 3.9M | 4.0M | 4.0M | 4.0M | 4.1M |
| Ebitda | -77.5M | -51.0M | -44.9M | -56.0M | 18.6M | -37.7M | -54.8M | -48.5M |
| Ebitdaratio | -12.12 | -1.681 | -1.51 | -2.621 | 0.209 | -1.779 | -2.265 | -2.175 |
| Operating Income Ratio | -13.04 | -1.90 | -1.763 | -2.963 | 0.136 | -2.421 | -2.566 | -2.513 |
| Income Before Tax | -90.1M | -67.1M | -61.9M | -70.9M | 6.1M | -51.2M | -59.6M | -53.0M |
| Income Before Tax Ratio | -14.086 | -2.213 | -2.083 | -3.318 | 0.068 | -2.413 | -2.463 | -2.377 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -14.086 | -2.213 | -2.083 | -3.318 | 0.068 | -2.413 | -2.463 | -2.377 |
| Epsdiluted | -1.72 | -1.30 | -1.20 | -1.38 | 0.12 | -1.01 | -1.17 | -1.05 |
| Weighted Average Shs Out | 52.4M | 51.8M | 51.7M | 51.5M | 51.4M | 50.9M | 50.8M | 50.6M |
| Weighted Average Shs Out Dil | 52.4M | 51.8M | 51.7M | 51.5M | 51.4M | 50.9M | 50.8M | 50.6M |